| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Advances in Brief |
Department of Radiation Oncology, Long Island Jewish Medical Center, The Long Island Campus for the Albert Einstein College of Medicine, New Hyde Park, New York 11040 [S. F., Q. M., J. G., M. Y., I. D. G., E. M. R.], and Department of Pharmacology and Toxicology, Medical College of Virginia, Commonwealth University, Richmond, Virginia 23298 [B. G.]
Epidemiological studies suggest that moderate alcohol consumption
increases the risk of breast cancer, and that alcohol combined with
estrogen replacement therapy may synergistically enhance the risk.
However, the mechanism(s) of alcohol-induced mammary cancer is unknown.
In human breast cancer cell lines, we found that ethanol (EtOH) caused
a dose-dependent increase of up to 10- to 15-fold in the
transcriptional activity of the liganded estrogen receptor (ER-
),
but did not activate the nonliganded receptor. Significant
stimulation of ER-
activity was observed at EtOH concentrations
comparable with or less than blood alcohol levels associated with
intoxication and at doses below the threshold for in
vitro cytotoxicity. These findings may be explained, in part,
by an EtOH-induced down-regulation of the expression of BRCA1, a
potent inhibitor of ER-
activity, and, in part, by a modest increase
in the ER-
levels. Our findings suggest that inactivation of
BRCA1 and increased estrogen-responsiveness might
contribute to alcohol-induced breast cancer.
This article has been cited by other articles:
![]() |
J. Q. Lew, N. D. Freedman, M. F. Leitzmann, L. A. Brinton, R. N. Hoover, A. R. Hollenbeck, A. Schatzkin, and Y. Park Alcohol and Risk of Breast Cancer by Histologic Type and Hormone Receptor Status in Postmenopausal Women: The NIH-AARP Diet and Health Study Am. J. Epidemiol., August 1, 2009; 170(3): 308 - 317. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Deandrea, R. Talamini, R. Foschi, M. Montella, L. Dal Maso, F. Falcini, C. La Vecchia, S. Franceschi, and E. Negri Alcohol and Breast Cancer Risk Defined by Estrogen and Progesterone Receptor Status: A Case-Control Study Cancer Epidemiol. Biomarkers Prev., August 1, 2008; 17(8): 2025 - 2028. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. G. Venkata, C. S. Aung, P. J. Cabot, G. R. Monteith, and S. J. Roberts-Thomson PPAR{alpha} and PPAR{beta} Are Differentially Affected by Ethanol and the Ethanol Metabolite Acetaldehyde in the MCF-7 Breast Cancer Cell Line Toxicol. Sci., March 1, 2008; 102(1): 120 - 128. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Zhang, I-M. Lee, J. E. Manson, N. R. Cook, W. C. Willett, and J. E. Buring Alcohol Consumption and Breast Cancer Risk in the Women's Health Study Am. J. Epidemiol., March 15, 2007; 165(6): 667 - 676. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Andrieu, D. E. Goldgar, D. F. Easton, M. Rookus, R. Brohet, A. C. Antoniou, S. Peock, G. Evans, D. Eccles, F. Douglas, et al. Pregnancies, breast-feeding, and breast cancer risk in the International BRCA1/2 Carrier Cohort Study (IBCCS). J Natl Cancer Inst, April 19, 2006; 98(8): 535 - 544. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Suzuki, W. Ye, T. Rylander-Rudqvist, S. Saji, G. A. Colditz, and A. Wolk Alcohol and Postmenopausal Breast Cancer Risk Defined by Estrogen and Progesterone Receptor Status: A Prospective Cohort Study J Natl Cancer Inst, November 2, 2005; 97(21): 1601 - 1608. [Abstract] [Full Text] [PDF] |
||||
![]() |
E M Rosen, S Fan, and C Isaacs BRCA1 in hormonal carcinogenesis: basic and clinical research Endocr. Relat. Cancer, September 1, 2005; 12(3): 533 - 548. [Abstract] [Full Text] [PDF] |
||||
![]() |
L Hilakivi-Clarke, C Wang, M Kalil, R Riggins, and R G Pestell Nutritional modulation of the cell cycle and breast cancer Endocr. Relat. Cancer, December 1, 2004; 11(4): 603 - 622. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Dumeaux, E. Lund, and A. Hjartaker Use of Oral Contraceptives, Alcohol, and Risk for Invasive Breast Cancer Cancer Epidemiol. Biomarkers Prev., August 1, 2004; 13(8): 1302 - 1307. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Cabanes, M. Wang, S. Olivo, S. DeAssis, J.-A. Gustafsson, G. Khan, and L. Hilakivi-Clarke Prepubertal estradiol and genistein exposures up-regulate BRCA1 mRNA and reduce mammary tumorigenesis Carcinogenesis, May 1, 2004; 25(5): 741 - 748. [Abstract] [Full Text] [PDF] |
||||
![]() |
D.-Y. Wang, R. Fulthorpe, S. N. Liss, and E. A. Edwards Identification of Estrogen-Responsive Genes by Complementary Deoxyribonucleic Acid Microarray and Characterization of a Novel Early Estrogen-Induced Gene: EEIG1 Mol. Endocrinol., February 1, 2004; 18(2): 402 - 411. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. I. Li, K. E. Malone, P. L. Porter, N. S. Weiss, M.-T. C. Tang, and J. R. Daling The Relationship between Alcohol Use and Risk of Breast Cancer by Histology and Hormone Receptor Status among Women 65-79 Years of Age Cancer Epidemiol. Biomarkers Prev., October 1, 2003; 12(10): 1061 - 1066. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. W. Singletary and S. M. Gapstur Alcohol and Breast Cancer: Review of Epidemiologic and Experimental Evidence and Potential Mechanisms JAMA, November 7, 2001; 286(17): 2143 - 2151. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. P. L. Bhat, D. Lantvit, K. Christov, R. G. Mehta, R. C. Moon, and J. M. Pezzuto Estrogenic and Antiestrogenic Properties of Resveratrol in Mammary Tumor Models Cancer Res., October 1, 2001; 61(20): 7456 - 7463. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |